Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMHJVOL)

Drug Name

Nabi-HB Drug Info

Synonyms

Reformulated HBV therapy, Nabi; Hepatitis B virus immune globulin (intramuscular), Nabi; H-BIG 5%iv formulation, Nabi

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Approved	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Hepatitis B virus Large envelope protein (HBV S)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NASVAC	DMIC56X	Hepatitis B virus infection	1E51.0	Phase 3	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis B virus Large envelope protein (HBV S)	TT6KSF7	HBSAG_HBVA3	Modulator	[2]

------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	Hepatitis B Immune Globulin (Human) Nabi-HB . US Food and Drug Administration report.
3	In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors. Mol Immunol. 2015 Feb;63(2):320-7.